| 1 | A bill to be entitled | 
| 2 | An act relating to compounded medicinal drugs; amending s. | 
| 3 | 465.003, F.S.; revising a definition; creating s. 465.055, | 
| 4 | F.S.; authorizing certain pharmacists and pharmacies to | 
| 5 | compound medicinal drugs and deliver such drugs to certain | 
| 6 | prescribers for the in-office use of the prescriber; | 
| 7 | authorizing certain pharmacists to dispense compounded | 
| 8 | medicinal drugs to certain prescribers; providing minimum | 
| 9 | standards to govern the dispensing of such compounded | 
| 10 | medicinal drugs; providing an effective date. | 
| 11 | 
 | 
| 12 | Be It Enacted by the Legislature of the State of Florida: | 
| 13 | 
 | 
| 14 | Section 1.  Subsection (6) of section 465.003, Florida | 
| 15 | Statutes, is amended to read: | 
| 16 | 465.003  Definitions.--As used in this chapter, the term: | 
| 17 | (6)  "Dispense" means the transfer of possession of one or | 
| 18 | more doses of a medicinal drug by a pharmacist to the ultimate | 
| 19 | consumer or her or his agent. As an element of dispensing, the | 
| 20 | pharmacist shall, prior to the actual physical transfer, | 
| 21 | interpret and assess the prescription order for potential | 
| 22 | adverse reactions, interactions, and dosage regimen she or he | 
| 23 | deems appropriate in the exercise of her or his professional | 
| 24 | judgment, and the pharmacist shall certify that the medicinal | 
| 25 | drug called for by the prescription is ready for transfer. The | 
| 26 | pharmacist shall also provide counseling on proper drug usage, | 
| 27 | either orally or in writing, if in the exercise of her or his | 
| 28 | professional judgment counseling is necessary. The actual sales | 
| 29 | transaction and delivery of such drug shall not be considered | 
| 30 | dispensing. The administration shall not be considered | 
| 31 | dispensing. For purposes of compounded medicinal drugs only, the | 
| 32 | term "ultimate consumer or her or his agent" shall specifically | 
| 33 | include an authorized prescriber, or his or her agent, using | 
| 34 | such compounded medicinal drugs for in-office use pursuant to s. | 
| 35 | 465.055. | 
| 36 | Section 2.  Section 465.055, Florida Statutes, is created | 
| 37 | to read: | 
| 38 | 465.055  Compounding for in-office use.-- | 
| 39 | (1)  Notwithstanding any other provision of law, a | 
| 40 | Florida-licensed pharmacist or a Florida-licensed pharmacy may | 
| 41 | compound a reasonable amount of a medicinal drug and deliver | 
| 42 | such drug to an authorized prescriber for such prescriber's | 
| 43 | administration or provision of the compounded medicinal drug to | 
| 44 | a patient by the prescriber or his or her agent, in the | 
| 45 | prescriber's primary practice office or any other state-licensed | 
| 46 | health care facility where the prescriber or his or her agent is | 
| 47 | authorized by law to prescribe or otherwise treat a patient with | 
| 48 | any prescription drug therapy. | 
| 49 | (2)  A Florida-licensed pharmacist may dispense a | 
| 50 | compounded medicinal drug for in-office use to a prescriber | 
| 51 | authorized by law to prescribe, administer, or otherwise treat a | 
| 52 | patient with such compounded medicinal drug. | 
| 53 | (3)  The amount of a compounded medicinal drug dispensed | 
| 54 | under this section shall not exceed the amount that either the | 
| 55 | prescriber or the pharmacist reasonably anticipates, based upon | 
| 56 | the exercise of each of such prescriber's or pharmacist's | 
| 57 | independent professional judgment, may be used by the prescriber | 
| 58 | for in-office use prior to the expiration date of all such | 
| 59 | compounded medicinal drug. | 
| 60 | (4)  The substantive quantity of a compounded medicinal | 
| 61 | drug dispensed under this section shall be reasonably | 
| 62 | calculated, based upon the pharmacist's understanding of the | 
| 63 | prescriber's intended use of such compounded drug given the | 
| 64 | nature of such prescriber's professional practice and the nature | 
| 65 | of the patient profiles served by such practice. | 
| 66 | (5)  The amount of a compounded medicinal drug dispensed | 
| 67 | under this section by the pharmacist shall be in compliance with | 
| 68 | the pharmaceutical standards for identity, strength, quality, | 
| 69 | and purity of the compounded drug that are consistent with the | 
| 70 | United States Pharmacopoeia guidelines and accreditation | 
| 71 | practices. | 
| 72 | (6)  A compounded medicinal drug provided by a pharmacist | 
| 73 | under this section shall be, under the independent professional | 
| 74 | judgment of the prescriber, medically necessary for a particular | 
| 75 | patient at the time of its delivery by the prescriber to the | 
| 76 | patient. | 
| 77 | (7)  A compounded medicinal drug, once dispensed under this | 
| 78 | section by the pharmacist, to the medical practitioner for in- | 
| 79 | office use, shall not be further subdivided for the purpose of | 
| 80 | retail distribution beyond what is otherwise deemed usual and | 
| 81 | customary. | 
| 82 | Section 3.  This act shall take effect July 1, 2007. |